PUBLISHER: The Insight Partners | PRODUCT CODE: 1206354
PUBLISHER: The Insight Partners | PRODUCT CODE: 1206354
The Middle East & Africa hydrocephalus shunts market is expected to grow from US$ 8.20 million in 2022 to US$ 9.39 million by 2028. It is estimated to grow at a CAGR of 2.3% from 2022 to 2028.
Increasing Prevalence of Hydrocephalus Boosts Middle East & Africa Hydrocephalus Shunts Market Growth
Cerebrospinal fluid (CSF) in the brain and spinal cord protects the central nervous system from injury and infection. The accumulation of excess CSF in brain cavities adds to intracranial pressure, thereby leading to hydrocephalus. The condition may further lead to macrocephaly and cognitive dysfunctions. The treatment approach of hydrocephalus highly focuses on managing CSF through medical devices named shunts. The shunt systems remove excess CSF from the brain and divert it to other body parts, wherein it is absorbed as a part of the circulatory process. Thus, the high incidence of hydrocephalus drives the demand for hydrocephalus shunts, thereby boosting the Middle East & Africa hydrocephalus shunts market growth.
Middle East & Africa Hydrocephalus Shunts Market Overview
The Middle East & Africa hydrocephalus shunts market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of MEA. The market growth in this region is ascribed to the increasing prevalence of neurological conditions, a rise in the geriatric population, and a surge in novel technological advancements. For instance, according to studies, the prevalence of neurodegenerative diseases in Arab countries ranges from 1.1% to 2.3% among people with age ≥50 and 13.5% to 18.5% among people with age ≥80. However, the lack of access to modern medical devices, such as hydrocephalus shunts, in low and middle-income countries may restrain the market growth.
Middle East & Africa Hydrocephalus Shunts Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Hydrocephalus Shunts Market Segmentation
The Middle East & Africa hydrocephalus shunts market is segmented into by age group, type, product, end user, and country.
Based on age group, the Middle East & Africa hydrocephalus shunts market is segmented into pediatric, and adults. The pediatric segment held the larger market share in 2022.
Based on type, the Middle East & Africa hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritonea. The ventriculo-peritoneal segment held the largest market share in 2022.
Based on product, the Middle East & Africa hydrocephalus shunts market is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves segment dominated the market share in 2022.
Based on end user, the Middle East & Africa hydrocephalus shunts market is segmented into hospitals, ambulatory surgical centers, others. The hospital segment dominated the market share in 2022.
Based on country, the Middle East & Africa hydrocephalus shunts market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East and Africa. The South Africa segment dominated the market share in 2022.
B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG); HpBio Proteses, inc.; Medtronic; Natus Medical Incorporated; Spiegelberg GmbH & Co. KG.; Integra LifeSciences Holdings Corporation, and Desu Medical are the leading companies operating in the Middle East & Africa hydrocephalus shunts market.